Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study

Purpose There is evidence to suggest that a nodal yield

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2014-09, Vol.21 (9), p.3049-3055
Hauptverfasser: Ebrahimi, Ardalan, Clark, Jonathan R., Amit, M., Yen, T. C., Liao, Chun-Ta, Kowalski, Luis P., Kreppel, Matthias, Cernea, Claudio R., Bachar, Gideon, Villaret, Andrea Bolzoni, Fliss, Dan, Fridman, Eran, Robbins, K. T., Shah, Jatin P., Patel, Snehal G., Gil, Ziv
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3055
container_issue 9
container_start_page 3049
container_title Annals of surgical oncology
container_volume 21
creator Ebrahimi, Ardalan
Clark, Jonathan R.
Amit, M.
Yen, T. C.
Liao, Chun-Ta
Kowalski, Luis P.
Kreppel, Matthias
Cernea, Claudio R.
Bachar, Gideon
Villaret, Andrea Bolzoni
Fliss, Dan
Fridman, Eran
Robbins, K. T.
Shah, Jatin P.
Patel, Snehal G.
Gil, Ziv
description Purpose There is evidence to suggest that a nodal yield
doi_str_mv 10.1245/s10434-014-3702-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551612148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551612148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-1b8815f0dd138fb5c8e5d9f3eef659979d76585a6c85e65d2d154db6fd75542c3</originalsourceid><addsrcrecordid>eNp1kdtqFTEYhYMotlYfwBsJeOPN1Jwn451sDy20VqgKXoXsyZ-akknaZAbaR_CtzXRXEcGbHP58a4XFQug5JYeUCfm6UiK46AgVHe8J624eoH0q20QoTR-2M1G6G5iSe-hJrZeE0J4T-RjtMdEzrRnfRz9PQwrTMuFP2dmIvweIDoeEz0q7nV8vdspLxRuIEW9sGUPKk32D34FvsnSB5x-Az2ebnC0OZ78ysMotPl3iHEZIMxR8vK7JziGn5vo55wgOf7MxuLtZc1jc7VP0yNtY4dn9foC-fnj_ZXPUnZx9PN68PelGIdjc0a3WVHriHOXab-WoQbrBcwCv5DD0g-uV1NKqUUtQ0jFHpXBb5V0vpWAjP0Cvdr5XJV8vUGczhTq2gDZBy2qolFRRRoVu6Mt_0Mu8tCDxjiKD4qznjaI7aiy51gLeXJUw2XJrKDFrT2bXk2k9mbUnc9M0L-6dl-0E7o_idzENYDugtqd0AeWvr__r-gsuSp5q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1550963273</pqid></control><display><type>article</type><title>Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Ebrahimi, Ardalan ; Clark, Jonathan R. ; Amit, M. ; Yen, T. C. ; Liao, Chun-Ta ; Kowalski, Luis P. ; Kreppel, Matthias ; Cernea, Claudio R. ; Bachar, Gideon ; Villaret, Andrea Bolzoni ; Fliss, Dan ; Fridman, Eran ; Robbins, K. T. ; Shah, Jatin P. ; Patel, Snehal G. ; Gil, Ziv</creator><creatorcontrib>Ebrahimi, Ardalan ; Clark, Jonathan R. ; Amit, M. ; Yen, T. C. ; Liao, Chun-Ta ; Kowalski, Luis P. ; Kreppel, Matthias ; Cernea, Claudio R. ; Bachar, Gideon ; Villaret, Andrea Bolzoni ; Fliss, Dan ; Fridman, Eran ; Robbins, K. T. ; Shah, Jatin P. ; Patel, Snehal G. ; Gil, Ziv</creatorcontrib><description>Purpose There is evidence to suggest that a nodal yield &lt;18 is an independent prognostic factor in patients with clinically node negative (cN0) oral squamous cell carcinoma (SCC) treated with elective neck dissection (END). We sought to evaluate this hypothesis with external validation and to investigate for heterogeneity between institutions. Patients and Methods We analyzed pooled individual data from 1,567 patients treated at nine comprehensive cancer centers worldwide between 1970 and 2011. Nodal yield was assessed with Cox proportional hazard models, stratified by study center, and adjusted for age, sex, pathological T and N stage, margin status, extracapsular nodal spread, time period of primary treatment, and adjuvant therapy. Two-stage random-effects meta-analyses were used to investigate for heterogeneity between institutions. Results In multivariable analyses of patients undergoing selective neck dissection, nodal yield &lt;18 was associated with reduced overall survival [hazard ratio (HR) 1.69; 95 % confidence interval (CI) 1.22–2.34; p  = 0.002] and disease-specific survival (HR 1.88; 95 % CI 1.21–2.91; p  = 0.005), and increased risk of locoregional recurrence (HR 1.53; 95 % CI 1.04–2.26; p  = 0.032). Despite significant differences between institutions in terms of patient clinicopathological factors, nodal yield, and outcomes, random-effects meta-analysis demonstrated no evidence of heterogeneity between centers in regards to the impact of nodal yield on disease-specific survival ( p  = 0.663; I 2 statistic = 0). Conclusion Our data confirm that nodal yield is a robust independent prognostic factor in patients undergoing END for cN0 oral SCC, and may be applied irrespective of the underlying patient population and treating institution. A minimum adequate lymphadenectomy in this setting should include at least 18 nodes.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-014-3702-x</identifier><identifier>PMID: 24728823</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Aged ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - secondary ; Carcinoma, Squamous Cell - surgery ; Female ; Follow-Up Studies ; Head and Neck Oncology ; Humans ; International Agencies ; Lymph Node Excision - standards ; Lymphatic Metastasis ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Mouth Neoplasms - mortality ; Mouth Neoplasms - pathology ; Mouth Neoplasms - surgery ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm Staging ; Oncology ; Prognosis ; Standard of Care ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Annals of surgical oncology, 2014-09, Vol.21 (9), p.3049-3055</ispartof><rights>Society of Surgical Oncology 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-1b8815f0dd138fb5c8e5d9f3eef659979d76585a6c85e65d2d154db6fd75542c3</citedby><cites>FETCH-LOGICAL-c442t-1b8815f0dd138fb5c8e5d9f3eef659979d76585a6c85e65d2d154db6fd75542c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-014-3702-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-014-3702-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24728823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimi, Ardalan</creatorcontrib><creatorcontrib>Clark, Jonathan R.</creatorcontrib><creatorcontrib>Amit, M.</creatorcontrib><creatorcontrib>Yen, T. C.</creatorcontrib><creatorcontrib>Liao, Chun-Ta</creatorcontrib><creatorcontrib>Kowalski, Luis P.</creatorcontrib><creatorcontrib>Kreppel, Matthias</creatorcontrib><creatorcontrib>Cernea, Claudio R.</creatorcontrib><creatorcontrib>Bachar, Gideon</creatorcontrib><creatorcontrib>Villaret, Andrea Bolzoni</creatorcontrib><creatorcontrib>Fliss, Dan</creatorcontrib><creatorcontrib>Fridman, Eran</creatorcontrib><creatorcontrib>Robbins, K. T.</creatorcontrib><creatorcontrib>Shah, Jatin P.</creatorcontrib><creatorcontrib>Patel, Snehal G.</creatorcontrib><creatorcontrib>Gil, Ziv</creatorcontrib><title>Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Purpose There is evidence to suggest that a nodal yield &lt;18 is an independent prognostic factor in patients with clinically node negative (cN0) oral squamous cell carcinoma (SCC) treated with elective neck dissection (END). We sought to evaluate this hypothesis with external validation and to investigate for heterogeneity between institutions. Patients and Methods We analyzed pooled individual data from 1,567 patients treated at nine comprehensive cancer centers worldwide between 1970 and 2011. Nodal yield was assessed with Cox proportional hazard models, stratified by study center, and adjusted for age, sex, pathological T and N stage, margin status, extracapsular nodal spread, time period of primary treatment, and adjuvant therapy. Two-stage random-effects meta-analyses were used to investigate for heterogeneity between institutions. Results In multivariable analyses of patients undergoing selective neck dissection, nodal yield &lt;18 was associated with reduced overall survival [hazard ratio (HR) 1.69; 95 % confidence interval (CI) 1.22–2.34; p  = 0.002] and disease-specific survival (HR 1.88; 95 % CI 1.21–2.91; p  = 0.005), and increased risk of locoregional recurrence (HR 1.53; 95 % CI 1.04–2.26; p  = 0.032). Despite significant differences between institutions in terms of patient clinicopathological factors, nodal yield, and outcomes, random-effects meta-analysis demonstrated no evidence of heterogeneity between centers in regards to the impact of nodal yield on disease-specific survival ( p  = 0.663; I 2 statistic = 0). Conclusion Our data confirm that nodal yield is a robust independent prognostic factor in patients undergoing END for cN0 oral SCC, and may be applied irrespective of the underlying patient population and treating institution. A minimum adequate lymphadenectomy in this setting should include at least 18 nodes.</description><subject>Aged</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - secondary</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Head and Neck Oncology</subject><subject>Humans</subject><subject>International Agencies</subject><subject>Lymph Node Excision - standards</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Mouth Neoplasms - mortality</subject><subject>Mouth Neoplasms - pathology</subject><subject>Mouth Neoplasms - surgery</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Standard of Care</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kdtqFTEYhYMotlYfwBsJeOPN1Jwn451sDy20VqgKXoXsyZ-akknaZAbaR_CtzXRXEcGbHP58a4XFQug5JYeUCfm6UiK46AgVHe8J624eoH0q20QoTR-2M1G6G5iSe-hJrZeE0J4T-RjtMdEzrRnfRz9PQwrTMuFP2dmIvweIDoeEz0q7nV8vdspLxRuIEW9sGUPKk32D34FvsnSB5x-Az2ebnC0OZ78ysMotPl3iHEZIMxR8vK7JziGn5vo55wgOf7MxuLtZc1jc7VP0yNtY4dn9foC-fnj_ZXPUnZx9PN68PelGIdjc0a3WVHriHOXab-WoQbrBcwCv5DD0g-uV1NKqUUtQ0jFHpXBb5V0vpWAjP0Cvdr5XJV8vUGczhTq2gDZBy2qolFRRRoVu6Mt_0Mu8tCDxjiKD4qznjaI7aiy51gLeXJUw2XJrKDFrT2bXk2k9mbUnc9M0L-6dl-0E7o_idzENYDugtqd0AeWvr__r-gsuSp5q</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Ebrahimi, Ardalan</creator><creator>Clark, Jonathan R.</creator><creator>Amit, M.</creator><creator>Yen, T. C.</creator><creator>Liao, Chun-Ta</creator><creator>Kowalski, Luis P.</creator><creator>Kreppel, Matthias</creator><creator>Cernea, Claudio R.</creator><creator>Bachar, Gideon</creator><creator>Villaret, Andrea Bolzoni</creator><creator>Fliss, Dan</creator><creator>Fridman, Eran</creator><creator>Robbins, K. T.</creator><creator>Shah, Jatin P.</creator><creator>Patel, Snehal G.</creator><creator>Gil, Ziv</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study</title><author>Ebrahimi, Ardalan ; Clark, Jonathan R. ; Amit, M. ; Yen, T. C. ; Liao, Chun-Ta ; Kowalski, Luis P. ; Kreppel, Matthias ; Cernea, Claudio R. ; Bachar, Gideon ; Villaret, Andrea Bolzoni ; Fliss, Dan ; Fridman, Eran ; Robbins, K. T. ; Shah, Jatin P. ; Patel, Snehal G. ; Gil, Ziv</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-1b8815f0dd138fb5c8e5d9f3eef659979d76585a6c85e65d2d154db6fd75542c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - secondary</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Head and Neck Oncology</topic><topic>Humans</topic><topic>International Agencies</topic><topic>Lymph Node Excision - standards</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Mouth Neoplasms - mortality</topic><topic>Mouth Neoplasms - pathology</topic><topic>Mouth Neoplasms - surgery</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Standard of Care</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimi, Ardalan</creatorcontrib><creatorcontrib>Clark, Jonathan R.</creatorcontrib><creatorcontrib>Amit, M.</creatorcontrib><creatorcontrib>Yen, T. C.</creatorcontrib><creatorcontrib>Liao, Chun-Ta</creatorcontrib><creatorcontrib>Kowalski, Luis P.</creatorcontrib><creatorcontrib>Kreppel, Matthias</creatorcontrib><creatorcontrib>Cernea, Claudio R.</creatorcontrib><creatorcontrib>Bachar, Gideon</creatorcontrib><creatorcontrib>Villaret, Andrea Bolzoni</creatorcontrib><creatorcontrib>Fliss, Dan</creatorcontrib><creatorcontrib>Fridman, Eran</creatorcontrib><creatorcontrib>Robbins, K. T.</creatorcontrib><creatorcontrib>Shah, Jatin P.</creatorcontrib><creatorcontrib>Patel, Snehal G.</creatorcontrib><creatorcontrib>Gil, Ziv</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimi, Ardalan</au><au>Clark, Jonathan R.</au><au>Amit, M.</au><au>Yen, T. C.</au><au>Liao, Chun-Ta</au><au>Kowalski, Luis P.</au><au>Kreppel, Matthias</au><au>Cernea, Claudio R.</au><au>Bachar, Gideon</au><au>Villaret, Andrea Bolzoni</au><au>Fliss, Dan</au><au>Fridman, Eran</au><au>Robbins, K. T.</au><au>Shah, Jatin P.</au><au>Patel, Snehal G.</au><au>Gil, Ziv</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>21</volume><issue>9</issue><spage>3049</spage><epage>3055</epage><pages>3049-3055</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Purpose There is evidence to suggest that a nodal yield &lt;18 is an independent prognostic factor in patients with clinically node negative (cN0) oral squamous cell carcinoma (SCC) treated with elective neck dissection (END). We sought to evaluate this hypothesis with external validation and to investigate for heterogeneity between institutions. Patients and Methods We analyzed pooled individual data from 1,567 patients treated at nine comprehensive cancer centers worldwide between 1970 and 2011. Nodal yield was assessed with Cox proportional hazard models, stratified by study center, and adjusted for age, sex, pathological T and N stage, margin status, extracapsular nodal spread, time period of primary treatment, and adjuvant therapy. Two-stage random-effects meta-analyses were used to investigate for heterogeneity between institutions. Results In multivariable analyses of patients undergoing selective neck dissection, nodal yield &lt;18 was associated with reduced overall survival [hazard ratio (HR) 1.69; 95 % confidence interval (CI) 1.22–2.34; p  = 0.002] and disease-specific survival (HR 1.88; 95 % CI 1.21–2.91; p  = 0.005), and increased risk of locoregional recurrence (HR 1.53; 95 % CI 1.04–2.26; p  = 0.032). Despite significant differences between institutions in terms of patient clinicopathological factors, nodal yield, and outcomes, random-effects meta-analysis demonstrated no evidence of heterogeneity between centers in regards to the impact of nodal yield on disease-specific survival ( p  = 0.663; I 2 statistic = 0). Conclusion Our data confirm that nodal yield is a robust independent prognostic factor in patients undergoing END for cN0 oral SCC, and may be applied irrespective of the underlying patient population and treating institution. A minimum adequate lymphadenectomy in this setting should include at least 18 nodes.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>24728823</pmid><doi>10.1245/s10434-014-3702-x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2014-09, Vol.21 (9), p.3049-3055
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_1551612148
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Aged
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - secondary
Carcinoma, Squamous Cell - surgery
Female
Follow-Up Studies
Head and Neck Oncology
Humans
International Agencies
Lymph Node Excision - standards
Lymphatic Metastasis
Male
Medicine
Medicine & Public Health
Middle Aged
Mouth Neoplasms - mortality
Mouth Neoplasms - pathology
Mouth Neoplasms - surgery
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - surgery
Neoplasm Staging
Oncology
Prognosis
Standard of Care
Surgery
Surgical Oncology
Survival Rate
title Minimum Nodal Yield in Oral Squamous Cell Carcinoma: Defining the Standard of Care in a Multicenter International Pooled Validation Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T15%3A48%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimum%20Nodal%20Yield%20in%20Oral%20Squamous%20Cell%20Carcinoma:%20Defining%20the%20Standard%20of%20Care%20in%20a%20Multicenter%20International%20Pooled%20Validation%20Study&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Ebrahimi,%20Ardalan&rft.date=2014-09-01&rft.volume=21&rft.issue=9&rft.spage=3049&rft.epage=3055&rft.pages=3049-3055&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-014-3702-x&rft_dat=%3Cproquest_cross%3E1551612148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1550963273&rft_id=info:pmid/24728823&rfr_iscdi=true